OCTAVE study reveals real-world vaccine response in patients with impaired immune systems

A scientist at the Centre for Cancer Immunology has been involved in a study that shows, for the first time, the real-world vaccine responses and infection outcomes in clinically at-risk patients with a range of immunocompromised or immunosuppressed conditions.

Breakthrough treatment for rare form of cancer

Clinician scientists in Southampton have shown a rare form of cancer can be treated with a drug that’s already available on the NHS.

Cancer scientists present research on world stage

Scientists and researchers from the Centre for Cancer Immunology have been presenting their work at several conferences across the globe over the past few weeks.

Centre professor appointed Cancer Mission Chair

A professor, based at the Centre for Cancer Immunology, has been appointed to a national role aiming to improve and expand cancer services in the UK.

Improving the way natural killer T cells fight cancer

Scientists at the Centre for Cancer Immunology are to begin a new study to better understand why certain natural killer T cells are more effective against cancer than others.

Major funding boost for clinical trials unit

The Southampton Clinical Trials Unit (SCTU) based at the Centre for Cancer Immunology has been given a multi-million-pound boost by Cancer Research UK.

Guernsey resident supported by Island donations to start PhD developing cancer vaccine

A Guernsey student is getting ready to start a four-year project, aiming to develop a vaccine that will fight cancer.

Antibody and Vaccine Group celebrated for innovative research

The Antibody and Vaccine Group (AVG) at the Centre for Cancer Immunology has been recognised for its innovative research by the British Society for Immunology.

New research to understand immune responses against COVID-19 vaccination

Centre for Cancer Immunology researchers are to lead a new landmark study to understand immune responses to COVID-19 vaccination.

New funding for head and neck cancer research

Centre researchers have received £1.38 million for a new research programme to improve immunotherapy treatment for head and neck cancer.